VCAM1 and inflammatory bowel disease: To evaluate the practicality of targeting VCAM-1 in colorectal diseases, this review discusses the recent progression of novel VCAM-1-directed therapeutics and their efficacy in clinical trials and experimental models of IBD and CRC.